Skip to content

Arrowhead Research ARWR Debt Repayments

Debt Repayments at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
$0-100%
Revvity logo
RevvityRVTY
$0+100%
Amgen logo
AmgenAMGN
$833M-66.7%
United Therapeutics logo
United TherapeuticsUTHR
$0-100%
Tenet Healthcare logo
Tenet HealthcareTHC
$33M+3.1%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$70M

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermLinesOfCredit.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's debt repayments?
Arrowhead Research (ARWR) reported debt repayments of $17.83M in Q1 2026.
How has Arrowhead Research's debt repayments changed year-over-year?
Arrowhead Research's debt repayments decreased by 88.2% year-over-year, from $151.63M to $17.83M.
What does debt repayments mean?
Cash used to pay back borrowed money.
How do you interpret debt repayments?
Higher repayment indicates a stronger balance sheet and reduced financial risk, provided it does not compromise operational liquidity.
How does debt repayments compare across companies?
Peers with high cash balances often prioritize debt repayment to optimize their capital structure.